277 related articles for article (PubMed ID: 30518036)
1. Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy.
Leary M; Heerboth S; Lapinska K; Sarkar S
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518036
[TBL] [Abstract][Full Text] [Related]
2. Cancer Progenitor Cells: The Result of an Epigenetic Event?
Lapinska K; Faria G; McGonagle S; Macumber KM; Heerboth S; Sarkar S
Anticancer Res; 2018 Jan; 38(1):1-6. PubMed ID: 29277749
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic aspects of breast cancer progression and therapy.
Byler S; Goldgar S; Heerboth S; Leary M; Housman G; Moulton K; Sarkar S
Anticancer Res; 2014 Mar; 34(3):1071-7. PubMed ID: 24596345
[TBL] [Abstract][Full Text] [Related]
4. Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.
Sarkar S; Goldgar S; Byler S; Rosenthal S; Heerboth S
Epigenomics; 2013 Feb; 5(1):87-94. PubMed ID: 23414323
[TBL] [Abstract][Full Text] [Related]
5. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
6. An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
Xylinas E; Hassler MR; Zhuang D; Krzywinski M; Erdem Z; Robinson BD; Elemento O; Clozel T; Shariat SF
Biomolecules; 2016 Sep; 6(3):. PubMed ID: 27598218
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in cancer: an overview.
Housman G; Byler S; Heerboth S; Lapinska K; Longacre M; Snyder N; Sarkar S
Cancers (Basel); 2014 Sep; 6(3):1769-92. PubMed ID: 25198391
[TBL] [Abstract][Full Text] [Related]
8. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries.
Wongtrakoongate P
World J Stem Cells; 2015 Jan; 7(1):137-48. PubMed ID: 25621113
[TBL] [Abstract][Full Text] [Related]
11. Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells.
Ponnusamy L; Mahalingaiah PKS; Chang YW; Singh KP
Eur J Pharm Sci; 2018 Oct; 123():56-69. PubMed ID: 30016648
[TBL] [Abstract][Full Text] [Related]
12. Tracing the origins of relapse in acute myeloid leukaemia to stem cells.
Shlush LI; Mitchell A; Heisler L; Abelson S; Ng SWK; Trotman-Grant A; Medeiros JJF; Rao-Bhatia A; Jaciw-Zurakowsky I; Marke R; McLeod JL; Doedens M; Bader G; Voisin V; Xu C; McPherson JD; Hudson TJ; Wang JCY; Minden MD; Dick JE
Nature; 2017 Jul; 547(7661):104-108. PubMed ID: 28658204
[TBL] [Abstract][Full Text] [Related]
13. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
[TBL] [Abstract][Full Text] [Related]
14. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.
Vijayaraghavalu S; Labhasetwar V
Drug Deliv Transl Res; 2018 Oct; 8(5):1289-1299. PubMed ID: 29947019
[TBL] [Abstract][Full Text] [Related]
15. Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment.
Zhang JT; Liu Y
Cancer Treat Rev; 2007 Dec; 33(8):741-56. PubMed ID: 17854999
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
Bewersdorf JP; Shallis R; Stahl M; Zeidan AM
Ther Adv Hematol; 2019; 10():2040620718816698. PubMed ID: 30719265
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma.
Furukawa Y; Kikuchi J
Int J Hematol; 2016 Sep; 104(3):281-92. PubMed ID: 27411688
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics and oncology.
Mummaneni P; Shord SS
Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Ward RJ; Autexier C
Mol Pharmacol; 2005 Sep; 68(3):779-86. PubMed ID: 15939802
[TBL] [Abstract][Full Text] [Related]
20. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
Shah K; Rawal RM
Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
